KEGG   DRUG: IratumumabHelp
Entry
D04612                      Drug                                   

Name
Iratumumab (USAN)
Efficacy
Antineoplastic, Anti-CD30 antibody
Comment
Monoclonal antibody
Treatment of relapsed or refractory CD30 positive lymphoma including Hodgkin's disease
Target
TNFRSF8 (CD30) [HSA:943] [KO:K05145]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   Tumor necrosis factor receptors
    TNFRSF8 (CD30)
     D04612  Iratumumab (USAN)
BRITE hierarchy
Other DBs
CAS: 640735-09-7
PubChem: 47206456
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system